GMRE vs. WT, TIGR, ESRT, PGRE, ELME, VRE, NAVI, LADR, NTST, and SILA
Should you be buying Global Medical REIT stock or one of its competitors? The main competitors of Global Medical REIT include WisdomTree (WT), UP Fintech (TIGR), Empire State Realty Trust (ESRT), Paramount Group (PGRE), Elme Communities (ELME), Veris Residential (VRE), Navient (NAVI), Ladder Capital (LADR), NETSTREIT (NTST), and Sila Realty Trust (SILA). These companies are all part of the "trading" industry.
Global Medical REIT vs. Its Competitors
WisdomTree (NYSE:WT) and Global Medical REIT (NYSE:GMRE) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation.
In the previous week, WisdomTree had 12 more articles in the media than Global Medical REIT. MarketBeat recorded 13 mentions for WisdomTree and 1 mentions for Global Medical REIT. WisdomTree's average media sentiment score of 0.72 beat Global Medical REIT's score of 0.00 indicating that WisdomTree is being referred to more favorably in the media.
WisdomTree has a net margin of 15.77% compared to Global Medical REIT's net margin of 5.87%. WisdomTree's return on equity of 25.46% beat Global Medical REIT's return on equity.
WisdomTree has higher revenue and earnings than Global Medical REIT. WisdomTree is trading at a lower price-to-earnings ratio than Global Medical REIT, indicating that it is currently the more affordable of the two stocks.
WisdomTree presently has a consensus price target of $12.99, indicating a potential upside of 2.10%. Global Medical REIT has a consensus price target of $10.44, indicating a potential upside of 43.47%. Given Global Medical REIT's higher probable upside, analysts plainly believe Global Medical REIT is more favorable than WisdomTree.
78.6% of WisdomTree shares are held by institutional investors. Comparatively, 57.5% of Global Medical REIT shares are held by institutional investors. 9.3% of WisdomTree shares are held by company insiders. Comparatively, 8.5% of Global Medical REIT shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
WisdomTree has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500. Comparatively, Global Medical REIT has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500.
WisdomTree pays an annual dividend of $0.12 per share and has a dividend yield of 0.9%. Global Medical REIT pays an annual dividend of $0.60 per share and has a dividend yield of 8.2%. WisdomTree pays out 34.3% of its earnings in the form of a dividend. Global Medical REIT pays out 2,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Summary
WisdomTree beats Global Medical REIT on 14 of the 18 factors compared between the two stocks.
Get Global Medical REIT News Delivered to You Automatically
Sign up to receive the latest news and ratings for GMRE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding GMRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Global Medical REIT Competitors List
Related Companies and Tools
This page (NYSE:GMRE) was last updated on 7/6/2025 by MarketBeat.com Staff